Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Altieri

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|February 8, 2020
Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral EvaluationFrancesca Curreli, Shahad Ahmed, Sofia M Benedict Victor, et al.
Bioorganic & Medicinal Chemistry|January 18, 2021
Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitorsFrancesca Curreli, Shahad Ahmed, Sofia M Benedict Victor, et al.
Journal of the American Chemical Society|July 2, 2011
Phosphorus-based functional groups as hydrogen bonding templates for rotaxane formationRehan Ahmed, Andrea Altieri, Daniel M D'Souza, et al.
Chemmedchem|July 16, 2016
Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13Mariangela Agamennone, Dmitry S Belov, Antonio Laghezza, et al.
European Journal of Medicinal Chemistry|July 11, 2021
Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacementsIldar R Iusupov, Francesca Curreli, Evgeniy A Spiridonov, et al.
Viruses|January 22, 2022
Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based AssaysFrancesca Curreli, Shahad Ahmed, Sofia M B Victor, et al.
Journal of Medicinal Chemistry|August 25, 2015
Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 ActivityFrancesca Curreli, Young Do Kwon, Hongtao Zhang, et al.
International Journal of Molecular Sciences|February 26, 2022
In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical ScreeningNunzio Iraci, Carmine Ostacolo, Alicia Medina-Peris, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2002
Photoisomerization of a rotaxane hydrogen bonding template: light-induced acceleration of a large amplitude rotational motionFrancesco G Gatti, Salvador León, Jenny K Y Wong, et al.
European Journal of Medicinal Chemistry|June 4, 2018
Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120Francesca Curreli, Dmitry S Belov, Young Do Kwon, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|February 8, 2020
Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral EvaluationFrancesca Curreli, Shahad Ahmed, Sofia M Benedict Victor, et al.
Bioorganic & Medicinal Chemistry|January 18, 2021
Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitorsFrancesca Curreli, Shahad Ahmed, Sofia M Benedict Victor, et al.
Journal of the American Chemical Society|July 2, 2011
Phosphorus-based functional groups as hydrogen bonding templates for rotaxane formationRehan Ahmed, Andrea Altieri, Daniel M D'Souza, et al.
Chemmedchem|July 16, 2016
Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13Mariangela Agamennone, Dmitry S Belov, Antonio Laghezza, et al.
European Journal of Medicinal Chemistry|July 11, 2021
Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacementsIldar R Iusupov, Francesca Curreli, Evgeniy A Spiridonov, et al.
Viruses|January 22, 2022
Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based AssaysFrancesca Curreli, Shahad Ahmed, Sofia M B Victor, et al.
Journal of Medicinal Chemistry|August 25, 2015
Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 ActivityFrancesca Curreli, Young Do Kwon, Hongtao Zhang, et al.
International Journal of Molecular Sciences|February 26, 2022
In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical ScreeningNunzio Iraci, Carmine Ostacolo, Alicia Medina-Peris, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2002
Photoisomerization of a rotaxane hydrogen bonding template: light-induced acceleration of a large amplitude rotational motionFrancesco G Gatti, Salvador León, Jenny K Y Wong, et al.
European Journal of Medicinal Chemistry|June 4, 2018
Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120Francesca Curreli, Dmitry S Belov, Young Do Kwon, et al.
Pageof 7